| Jul 23 |
FSD Pharma Inc. Announces Results of Annual General and Special Meeting of Shareholders
|
| Jul 23 |
24/7 Market News Publishes Report Covering Biotech Developments, Featuring FSD Pharma
|
| Jul 4 |
FSD Pharma Files Amended and Restated Material Change Report
|
| Jun 28 |
FSD Pharma provides Corporate Update
|
| Jun 28 |
Update: FSD Pharma $2 Million Arbitration Award Upheld by Federal Court Against Former CEO
|
| Jun 28 |
FSD Pharma, Inc. Wins Final Judgment to Confirm Arbitration Award of $3,059,998 Plus Interest Entered Against Dr. Raza Bokhari, Currently Serving as Chairman and CEO of Medicus Pharma Ltd.
|
| Jun 27 |
FSD Pharma Receives Ethics Committee Approval for a Phase-1 Multiple Ascending Doses Clinical Trial for Lucid-21-302 (Lucid-MS) in Australia
|
| Jun 4 |
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
|
| May 28 |
FSD Pharma Submits a Clinical Trial Protocol to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
|
| May 24 |
FSD Pharma Provides Corporate Update
|
